Structural Properties of AMP-activated Protein Kinase: Dimerization, Molecular Shape, and Changes Upon Ligand Binding
Overview
Authors
Affiliations
Heterotrimeric AMP-activated protein kinase (AMPK) is crucial for energy homeostasis of eukaryotic cells and organisms. Here we report on (i) bacterial expression of untagged mammalian AMPK isoform combinations, all containing gamma(1), (ii) an automated four-dimensional purification protocol, and (iii) biophysical characterization of AMPK heterotrimers by small angle x-ray scattering in solution (SAXS), transmission and scanning transmission electron microscopy (TEM, STEM), and mass spectrometry (MS). AMPK in solution at low concentrations (~1 mg/ml) largely consisted of individual heterotrimers in TEM analysis, revealed a precise 1:1:1 stoichiometry of the three subunits in MS, and behaved as an ideal solution in SAXS. At higher AMPK concentrations, SAXS revealed concentration-dependent, reversible dimerization of AMPK heterotrimers and formation of higher oligomers, also confirmed by STEM mass measurements. Single particle reconstruction and averaging by SAXS and TEM, respectively, revealed similar elongated, flat AMPK particles with protrusions and an indentation. In the lower AMPK concentration range, addition of AMP resulted in a significant decrease of the radius of gyration by approximately 5% in SAXS, which indicates a conformational switch in AMPK induced by ligand binding. We propose a structural model involving a ligand-induced relative movement of the kinase domain resulting in a more compact heterotrimer and a conformational change in the kinase domain that protects AMPK from dephosphorylation of Thr(172), thus positively affecting AMPK activity.
FRET-Based Sensor for Measuring Adenine Nucleotide Binding to AMPK.
Abi Nahed R, Pelosse M, Aulicino F, Cottaz F, Berger I, Schlattner U Methods Mol Biol. 2025; 2882:15-45.
PMID: 39992503 DOI: 10.1007/978-1-0716-4284-9_2.
The pro-drug C13 activates AMPK by two distinct mechanisms.
Freemantle J, Shah D, Lynch D, Ciulli A, Hundal H, Grahame Hardie D Biochem J. 2024; 481(18):1203-1219.
PMID: 39222030 PMC: 11555695. DOI: 10.1042/BCJ20240425.
Sarankhuu B, Jeon H, Jeong D, Park S, Kim T, Lee S Mol Med Rep. 2024; 30(4).
PMID: 39155876 PMC: 11350624. DOI: 10.3892/mmr.2024.13308.
BAY-3827 and SBI-0206965: Potent AMPK Inhibitors That Paradoxically Increase Thr172 Phosphorylation.
Hawley S, Russell F, Ross F, Grahame Hardie D Int J Mol Sci. 2024; 25(1).
PMID: 38203624 PMC: 10778976. DOI: 10.3390/ijms25010453.
Ma C, Tsai H, Zhang Q, Senavirathna L, Li L, Chin L Int J Mol Sci. 2022; 23(15).
PMID: 35897829 PMC: 9331968. DOI: 10.3390/ijms23158251.